12:00 AM
 | 
Oct 06, 2008
 |  BC Week In Review  |  Company News  |  Deals

Arisyn Therapeutics, University of Arizona Foundation deal

Arisyn acquired a portfolio of the foundation's small molecule inhibitors to treat cancer and viral diseases. The deal includes candidates in...

Read the full 82 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >